PROQR THERAPEUTICS NV

PRQR is the Nasdaq ticker symbol for ProQR Therapeutics N.V., a clinical-stage biopharmaceutical company. The stock represents equity ownership in the company, which trades on the Nasdaq Capital Market under this symbol. PRQR shares are typically followed by investors interested in biotechnology and RNA-based therapeutic development.

PRQR, through ProQR Therapeutics, focuses on developing RNA-based medicines for genetic diseases. Its pipeline has included programs targeting inherited retinal dystrophies and other conditions with high unmet need. Because candidates are largely in clinical or preclinical stages, the company's progress depends on trial results, regulatory interactions, and partnership or financing developments.

Recent performance for PRQR depends on current market trading and company-specific news. For the latest price changes, trading volume, and percentage moves, refer to the PRQR quote and performance data displayed on this page. Those figures reflect the most recent market close and any after-hours activity shown by the data provider.

Evaluating PRQR requires methods suited to a clinical-stage biopharmaceutical company, where earnings and revenue may be limited or absent. Investors often review cash balances, cash burn, pipeline progress, partnership terms, and potential market opportunities. Traditional metrics such as the P/E ratio may not be meaningful, so the latest PRQR valuation and financial data on this page should be used.

PRQR may be available for pre-market and after-hours trading through certain brokers, depending on the venue and liquidity. Extended-hours sessions often have wider spreads and lower volume than regular Nasdaq trading hours. Availability and execution can vary by broker, so investors should check their platform for specific PRQR extended-hours trading details.

Earnings information for PRQR is typically available through ProQR Therapeutics' investor relations website, SEC filings, and the financial data sections of major stock platforms. Quarterly reports and annual filings provide updates on cash position, operating expenses, and pipeline milestones. For the latest reported figures, refer to the PRQR earnings and financial statements displayed on this page.